Down Under-represented

Down Under-represented I just wanted to make one comment regarding your surveys and information gathering: I think it is important that when discussing employment issues, lab politics, or general science issues, you should remember that quality science is generated from places other than the Northern hemisphere. That is, there are other thriving, first-world economies that are underrepresented in your discussions (e.g., Australia). Given that many 'Southern' scientists have the option of e

Written byPaige Hilditch-Maguire
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I just wanted to make one comment regarding your surveys and information gathering: I think it is important that when discussing employment issues, lab politics, or general science issues, you should remember that quality science is generated from places other than the Northern hemisphere. That is, there are other thriving, first-world economies that are underrepresented in your discussions (e.g., Australia).

Given that many 'Southern' scientists have the option of either remaining in Australia, or like me, repatriating after completing postdoctoral positions in first-rate labs in the United States and United Kingdom, valuable information can be gathered from these people. (I think the general impression is that the "foreign scientists" in surveys are those who have left eastern/underdeveloped countries for greener pastures.) I appreciate that your wider market is Northern America, but please try and be aware of those in other parts of the globe who also thrive in this field.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies